Clinical Trial Update: A Study on TLC590 for Managing Postsurgical Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on TLC590 for managing postoperative pain is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• TLC590

Snippet

Sponsor: TLC Biopharmaceuticals, Inc. | Conditions: Postsurgical Pain Management | Phase 2 | Status: RECRUITING